A multi-national, multi-institutional study investigators found little natural resistance to a new HIV therapy called lenacapavir in a population of patients in Uganda.
A multi-national, multi-institutional study led by Weill Cornell Medicine investigators found little natural resistance to a ...
Vimkunya is supplied as an injectable suspension; the vaccine is administered intramuscularly as a single 0.8mL dose.
ImmunityBio, Inc. , a leading immunotherapy company, today announced the U.S. Food and Drug Administration (FDA) has authorized an expanded access program (EAP) that will bring a vital alternative ...
The Recombinant DNA Technology Market size is expected to be worth around USD 1288.5 Bn by 2032 from USD 786.7 Bn in 2023, growing at a CAGR of 5.8% As scientific and technological advancements ...
First chikungunya vaccine approved for persons as young as 12 years old, addressing an unmet need for chikungunya prevention for younger ...
First chikungunya vaccine approved for persons as young as 12 years old, addressing an unmet need for chikungunya prevention for younger travelers.On track for commercial launch in the U.S. in the ...
The influenza A virus genome consists of eight segments of single-stranded, negative-sense viral RNA, which encode multiple ...
It is also the first clinical trial of the vaccine during an outbreak Kampala, Uganda | AGENCIES | In a global first, ...
With egg prices returning to sky-high levels, there's a major opportunity for plant-based and fermentation-derived ...
Subsidies and existing MediSave schemes could possibly bring the out-of-pocket cost of Shingrix down to zero, says Health ...
Dr. Paulo H. Verardi, a virologist and head of the Department of Pathobiology and Veterinary Science at the University of ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果